The burden of blood disorders on European society is estimated at €23 billion per year1. The Global Business Partnership Agreement between Roche and Sysmex stands to benefit patients in need of diagnostic solutions and will help laboratories to streamline their testing efficiency and effectiveness through integrated IVD technologies from a single service provider. About Roche Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world's largest biotechnology company and the global leader in in-vitro diagnostics.